Sign Up to like & get
recommendations!
1
Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1838
Abstract: This article provides a summary of the recent NICE recommendations on the use of cannabis‐based medicinal products (CBMPs) in the treatment of epilepsy, spasticity, pain, and nausea and vomiting. It also discusses the guidance on…
read more here.
Keywords:
based medicinal;
medicinal products;
cannabis based;
use cannabis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Neuropediatrics"
DOI: 10.1055/a-2002-2119
Abstract: Abstract Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment of treatment-resistant epilepsy (TRE) in children. Methods A case series of children (
read more here.
Keywords:
cannabis;
cannabis based;
medicinal products;
based medicinal ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Current drug delivery"
DOI: 10.2174/1567201819666220126163943
Abstract: Psoriasis is an autoimmune skin disorder that is characterised by chronic inflammation and erythematous scaly patches. It has a significant impact on the patient's quality of life and can cause psychological stress. There are several…
read more here.
Keywords:
treatment psoriasis;
nanotechnology;
nanotechnology based;
based medicinal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Pharmaceuticals"
DOI: 10.3390/ph13030037
Abstract: Imidazole and its derivatives are one of the most vital and universal heterocycles in medicinal chemistry. Owing to their special structural features, these compounds exhibit a widespread spectrum of significant pharmacological or biological activities, and…
read more here.
Keywords:
van leusen;
medicinal molecules;
based medicinal;
imidazole based ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical medicine"
DOI: 10.7861/clinmed.21-2-s29
Abstract: Unlicensed cannabis-based medicinal products (UCBPMs) were reclassified from Schedule 1 to Schedule 2 in 2018 in the UK, allowing doctors on the Specialist Register of the General Medical Council to legally issue prescriptions for UCBPMs.[1,2][1]…
read more here.
Keywords:
platform developed;
based medicinal;
medicinal products;
cannabis based ... See more keywords